Abstract
Ischaemic stroke is one of the most common diseases world-wide. Recent studies provide new insights into the role of ATPbinding cassette (ABC) transporters in brain ischaemia. Expressional and functional transporter changes that have been observed at the brain capillary endothelium during ischaemia impede the access of pharmacological compounds into the brain tissue. The current review summarizes the most important findings and discusses the role of hypoxia, inflammation, oxidative stress and lipids as factors regulating ABC transporters at the blood-brain barrier. A better understanding of biodistribution processes at the blood-brain barrier is urgently needed, so that the accumulation of drugs in the brain can be improved, enabling a successful translation of pharmacological treatments in ischaemic stroke.
Keywords: Ischaemic stroke, ABC transporters, multidrug resistance, blood-brain barrier, immunohistochemistry, Apolipoprotein E, Thrombolysis, hypoxia, Metabolic imbalance, oxidative stress
Current Pharmaceutical Design
Title: ATP-Binding Cassette Transporters at the Blood-Brain Barrier in Ischaemic Stroke
Volume: 17 Issue: 26
Author(s): Pauline Patak and Dirk M. Hermann
Affiliation:
Keywords: Ischaemic stroke, ABC transporters, multidrug resistance, blood-brain barrier, immunohistochemistry, Apolipoprotein E, Thrombolysis, hypoxia, Metabolic imbalance, oxidative stress
Abstract: Ischaemic stroke is one of the most common diseases world-wide. Recent studies provide new insights into the role of ATPbinding cassette (ABC) transporters in brain ischaemia. Expressional and functional transporter changes that have been observed at the brain capillary endothelium during ischaemia impede the access of pharmacological compounds into the brain tissue. The current review summarizes the most important findings and discusses the role of hypoxia, inflammation, oxidative stress and lipids as factors regulating ABC transporters at the blood-brain barrier. A better understanding of biodistribution processes at the blood-brain barrier is urgently needed, so that the accumulation of drugs in the brain can be improved, enabling a successful translation of pharmacological treatments in ischaemic stroke.
Export Options
About this article
Cite this article as:
Patak Pauline and M. Hermann Dirk, ATP-Binding Cassette Transporters at the Blood-Brain Barrier in Ischaemic Stroke, Current Pharmaceutical Design 2011; 17 (26) . https://dx.doi.org/10.2174/138161211797440195
DOI https://dx.doi.org/10.2174/138161211797440195 |
Print ISSN 1381-6128 |
Publisher Name Bentham Science Publisher |
Online ISSN 1873-4286 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Serotonin Reuptake Inhibitors and Cardiovascular Disease
Vascular Disease Prevention (Discontinued) Pharmacological Neuroprotective Therapy for Acute Spinal Cord Injury: State of the Art
Mini-Reviews in Medicinal Chemistry Mst1: Function and Mechanism in Brain and Myocardial Ischemia Reperfusion Injury
Current Neuropharmacology Heme Oxygenase-1/CO as Protective Mediators in Cigarette Smoke- Induced Lung Cell Injury and Chronic Obstructive Pulmonary Disease
Current Pharmaceutical Biotechnology The Use of Dexmedetomidine in Anesthesia and Intensive Care: A Review
Current Pharmaceutical Design Pharmacological manipulation of peripheral vascular resistance in special clinical situations after pediatric cardiac surgery
Current Vascular Pharmacology Immune Mechanisms and Novel Pharmacological Therapies of Acute Kidney Injury
Current Drug Targets The Role of the Chemokines in Myocardial Ischemia and Reperfusion
Current Vascular Pharmacology Oxytocin as a Potential Adjuvant Against COVID-19 Infection
Endocrine, Metabolic & Immune Disorders - Drug Targets Glycyrrhizic Acid Ameliorates Cognitive Impairment in a Rat Model of Vascular Dementia Associated with Oxidative Damage and Inhibition of Voltage-Gated Sodium Channels
CNS & Neurological Disorders - Drug Targets Polyphenols and Aging
Current Aging Science Tyrosine Kinase Inhibitor as a new Therapy for Ischemic Stroke and other Neurologic Diseases: is there any Hope for a Better Outcome?
Current Neuropharmacology Perinatal Heart Programming: Long-term Consequences
Current Medicinal Chemistry Sweet and Sour - Oxidative and Carbonyl Stress in Neurological Disorders
CNS & Neurological Disorders - Drug Targets Pulmonary Arterial Hypertension: Need to Treat
Inflammation & Allergy - Drug Targets (Discontinued) Neonatal Brain Hemorrhage (NBH) of Prematurity: Translational Mechanisms of the Vascular-Neural Network
Current Medicinal Chemistry Effect of Aging on Metabolic Pathways in Endothelial Progenitor Cells
Current Pharmaceutical Design Fatty Acid Synthase: A Target for the Reversal of Liver Steatosis
Current Enzyme Inhibition A Review of the Chemical and Pharmacological Aspects of the Genus Marrubium
Current Pharmaceutical Design Enzyme / Abzyme Prodrug Activation Systems: Potential Use in Clinical Oncology
Current Pharmaceutical Design